Today 29 patient and consumer groups representing millions of people nationwide with pre-existing health conditions issued the following statement in response to administration’s final rule. The rule, finalized Friday, attempts to undermine Section 1557 of the Affordable Care Act by removing explicit protections against discrimination of patients by providers and institutions.
A new survey shows that cancer patients are being impacted by COVID-19.
Untold insecurities weigh heavily on many Oklahomans, and on June 30, voters can ease some of that worry by voting ‘yes’ on State Question 802.
Today the U.S. House of Representatives will vote on the Heroes Act, a package of legislative proposals aimed at addressing numerous pandemic-related health, research and economic relief needs. Included in the bill are several provisions that would make it easier for Americans to maintain or gain health insurance coverage.
Twenty patient groups representing millions of Americans with pre-existing conditions filed an amicus curiae (“friend-of-the-court”) brief today with the U.S. Supreme Court in the case California v. Texas (previously Texas v. United States), citing the devastating impact patients would face should the court rule to invalidate the Affordable Care Act (ACA).
he Centers for Medicare and Medicaid Services (CMS) recently issued a proposed rule detailing how the government would cover costs for Chimeric antigen receptor (CAR) T-cell cancer therapy for Medicare enrollees.
Legislation introduced in the U.S. House of Representatives today aims to improve access to quality health care for communities of color and decrease health disparities, such as those resulting in a disproportionate number of COVID-19 cases and deaths in these communities.
Cancer patients and those who’ve recently completed treatment are finding it challenging to get necessary health care in the midst of the COVID-19 pandemic and many are experiencing financial stress trying to afford care in an increasingly difficult economic environment.
In response to the N.C. General Assembly’s call for policy recommendations addressing the COVID-19 pandemic, the American Cancer Society Cancer Action Network (ACS CAN) of North Carolina, is advocating for the following:
Learn about the real life impact of prior authorization from two cancer patients who have dealt with this issue firsthand.